Abstract

Aspirin-exacerbated respiratory disease (AERD) is a syndrome that includes nasal polyposis, asthma, and nonsteroidal anti-inflammatory drug sensitivity. This clinical triad is seen in about 7% of adults with asthma, and in about 15% of those with severe asthma,1 with the average age of onset being 34 years. A positive aspirin-induced reaction during a provocative aspirin challenge is the current standard for confirmative diagnosis.2 Aspirin desensitization, followed by initiation of daily high-dose aspirin therapy, is often used to help reduce nasal polyposis and asthma symptoms in these patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call